Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Galenica AG ( (CH:GALE) ) has provided an update.
Galenica AG has increased its stake in Puravita AG to 80%, enhancing its digital presence and diversifying its business. This move strengthens Galenica’s online offerings in the drugstore and health food sectors, aligning with its strategy to integrate digital and physical services. Puravita, with its substantial online assortment and market experience, will benefit from Galenica’s logistics and marketing infrastructure, further driving growth in the health and well-being market.
The most recent analyst rating on (CH:GALE) stock is a Hold with a CHF85.00 price target. To see the full list of analyst forecasts on Galenica AG stock, see the CH:GALE Stock Forecast page.
More about Galenica AG
Galenica AG is a Swiss company listed on the SIX Swiss Exchange, specializing in the healthcare sector. It operates a broad network of pharmacies, offers pharmaceutical logistics, and provides various products and services, including home care. The company is committed to enhancing the Swiss healthcare system through its extensive expertise and partnerships.
Average Trading Volume: 94,667
Technical Sentiment Signal: Buy
Current Market Cap: CHF4.65B
Learn more about GALE stock on TipRanks’ Stock Analysis page.